Download full-text PDF

Source
http://dx.doi.org/10.1111/jocd.14877DOI Listing

Publication Analysis

Top Keywords

commentary "the
4
"the 577-nm
4
577-nm pro-yellow
4
pro-yellow laser
4
laser demodex
4
demodex density
4
density patients
4
patients rosacea"
4
commentary
1
577-nm
1

Similar Publications

Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel.

Neurol Ther

January 2025

Department of Psychiatry, Faculty of Medicine, Mental Health Unit, Virgen del Rocio University Hospital, Translational Psychiatry Group, IBiS-CSIC, CIBERSAM, University of Seville, Seville, Spain.

Introduction: For patients with psychosis, early, intensive therapeutic intervention is thought to improve long-term outcomes. Furthermore, patients with a first-episode psychosis (FEP) who experience a good early response to antipsychotic medication show a clinical and functional benefit over the longer term if they continue low-dose antipsychotic treatment. Lurasidone is an atypical antipsychotic agent which is approved in Europe for the treatment of schizophrenia in adults and adolescents (13-17 years).

View Article and Find Full Text PDF

Introduction: Amblyopia, the leading cause of monocular childhood vision loss, affects millions and is projected to increase. Early detection and treatment are crucial for preventing vision impairment.

Areas Covered: This commentary reviews the current state and opportunities for improvement in amblyopia screening strategy and technology focused primarily within the United States.

View Article and Find Full Text PDF

Where are the lone pairs? QC and QCT.

Acta Crystallogr C Struct Chem

February 2025

Facultad de Química, Universidad Nacional Autónoma de México, México City, Mexico.

The article by Guzmán-Hernández & Jancik [(2024). Acta Cryst. C80, 766-774] is an excellent example of how QC-QCT (quantum crystallography-quantum chemical topology) methodology can extract structural information from a crystal.

View Article and Find Full Text PDF

Attention-deficit/hyperactivity disorder (ADHD) is a treatable pediatric condition, but children with racial-ethnic minority backgrounds often do not receive timely or consistent treatment. Understanding how systemic racism impacts care and learning from families of color about their experiences can provide critical insights for improving clinical practice and engaging patients equitably in ADHD care. We interweave a mother's experience navigating ADHD care for her son with commentary from an interprofessional team about what clinicians can do for families to reduce the impact of systemic racism on care.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!